Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-03 · accession 0001209191-22-016876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-07 | 2022-03-03 | PCRX | PACE GARY W | Dir | M - OptEx | $10.81 | +7,000 | 136.5K | +5% | +$75.7K |
| D | 2022-03-07 | 2022-03-03 | PCRX | PACE GARY W | Dir | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-03 | M | A | 7,000 | $10.81 | 136,530 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-03 | M | D | 7,000 | $0.00 | 0 | D | $10.81 · — to 2022-06-04 | 7,000 Common Stock | (F1) The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 5, 2012. |